Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, dedicated to innovating therapies for cancer and viral infections. Utilizing its proprietary technology, Moleculin is advancing a diverse pipeline of drug candidates designed to address resistant tumors and unmet needs in oncology. The company's strong focus on scientific research and development positions it favorably to make significant strides in cancer treatment, ultimately contributing to improved patient outcomes in a challenging therapeutic landscape. Show more

Location: 5300 MEMORIAL DRIVE, HOUSTON, TX, UNITED STATES, 77007, Houston, TX, 77007, USA | Website: https://moleculin.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

22.47M

52 Wk Range

$3.13 - $91.25

Previous Close

$3.91

Open

$4.16

Volume

158,241

Day Range

$3.85 - $4.39

Enterprise Value

6.651M

Cash

6.703M

Avg Qtr Burn

-7.223M

Insider Ownership

1.65%

Institutional Own.

3.90%

Qtr Updated

06/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Annamycin + Ara-C (Cytarabine) Details Acute myeloid leukemia (AML)	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Annamycin/Naxtarubicin (Anthracycline Chemotherapy) Details Pancreatic Cancer, Third Line	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WP1066 Details Cancer, Brain tumor, Solid tumor/s, Glioma	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WP1066 Details Brain tumor, Solid tumor/s, Cancer, Glioblastoma	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Annamycin Details Soft Tissue Sarcoma Lung Metastases	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WP1122 Details Cancer, Glioblastoma, Brain tumor, Solid tumor/s	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WP1220 Details Cutaneous T cell lymphoma, Blood cancer, Cancer, T-cell lymphoma	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
WP1122 Details COVID-19	Phase 1a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.